Stock GLPG GALAPAGOS NV
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Galapagos NV

Equities

GLPG

BE0003818359

Market Closed - Euronext Amsterdam
Other stock markets
 11:35:14 2024-04-29 EDT 		After market 15:59:47
26.76 EUR +0.30% Intraday chart for Galapagos NV 26.58 -0.67%
04-08 Galapagos Showcases Innovative Approach in Hematological Cancer Care with Clinical and Translational Data Presentations at EBMT Congress 2024 CI
03-28 Galapagos Continues to be 'Value Trap' With Unclear Growth Path, BofA Says MT

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Galapagos : Galapagos showcases innovative approach in hematological cancer care with clinical and translational data presentations at EBMT congress 2024
PU
Galapagos showcases innovative approach in hematological cancer care with clinical and translational data presentations at EBMT congress 2024
GL
Galapagos : Galapagos publishes 2023 annual report and announces Annual and Extraordinary Shareholders’ Meetings
PU
Galapagos publishes 2023 annual report and announces Annual and Extraordinary Shareholders’ Meetings
GL
Galapagos : Galapagos benoemt Andrew Dickinson tot Niet-Uitvoerend, Niet-Onafhankelijk Bestuurder van haar Raad van Bestuur
PU
Galapagos appoints Andrew Dickinson as Non-Executive Non-Independent Director to its Board
GL
Galapagos announces full year 2023 results and outlook for 2024
GL
Galapagos presents at EBMT-EHA annual meeting 2024
GL
Galapagos presents at EBMT-EHA annual meeting 2024
AQ
Galapagos completes transaction to transfer Jyseleca® business to Alfasigma
GL
Galapagos enters into strategic collaboration agreement with Thermo Fisher Scientific to further expand its decentralized CAR-T manufacturing network in the U.S.
GL
Galapagos enters into strategic collaboration agreement with Thermo Fisher Scientific to further expand its decentralized CAR-T manufacturing network in the U.S.
AQ
Galapagos establishes strategic collaboration with BridGene Biosciences to expand small molecule drug discovery in oncology
GL
Galapagos signs agreement to transfer Jyseleca business to Alfasigma
AQ
Galapagos : Galapagos signs agreement to transfer Jyseleca® business to Alfasigma
PU
Galapagos signs agreement to transfer Jyseleca® business to Alfasigma
GL
Galapagos signs agreement to transfer Jyseleca® business to Alfasigma
AQ
Galapagos announces start of PAPILIO-1 Phase 1/2 multiple myeloma study of point-of-care manufactured BCMA CAR-T candidate, GLPG5301
GL
Galapagos announces start of PAPILIO-1 Phase 1/2 multiple myeloma study of point-of-care manufactured BCMA CAR-T candidate, GLPG5301
AQ
Galapagos presents new encouraging data at ASH 2023 from ongoing CD19 CAR-T studies with GLPG5201 and GLPG5101
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. GLPG Stock
  4. News Galapagos NV
  5. Press Releases